Literature DB >> 3694005

Response to repetitive cycles of ovulation induction in the same women.

M P Diamond1, A H DeCherney, G A Hill, F Nero, A C Wentz.   

Abstract

It has been theorized that the administration of human menopausal gonadotropin (hMG) in consecutive menstrual cycles will result in a poor follicular response in the second cycle. To examine this, 50 women undergoing ovulation induction in two consecutive cycles were assessed, using in each the same induction regimen during the initial 5 days. The remainder of each cycle was individualized according to their response. Nine women were anovulatory, 19 were oligoovulatory, and 22 ovulated regularly in unstimulated cycles. In repeat cycles only 3 of 50 had poor follicular development and did not receive human chorionic gonadotropin (hCG); all were anovulatory. Forty-two of 50 of the first cycles had continually rising estradiol (E2), while 43 of 47 of the second cycles had rising E2 patterns. Grouping the peak E2 prior to hCG in the ranges less than 300, 300-699, 700-1099, and greater than or equal to 1100 pg/ml, peaks in the second cycle were similar in 25 of 50, lower in 16, and higher in 9. Only 3 of 9 anovulatory women had similar peaks, as compared to 22 of 41 of the oligoovulatory and regularly ovulating women. Comparing the second to the first cycle, the day of hCG was within 1 day in 28 of 50 women, 2 or more days less than the first cycle in 6, and 2 or more days greater than the first cycle in 11. We conclude that in a successive cycle of ovulation induction (i) the follicular response is impaired in anovulatory women, but (ii) in oligoovulatory or regularly ovulating women, clinically significant differences in the estradiol response do not occur.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694005     DOI: 10.1007/bf01555198

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


  19 in total

Review 1.  Ovulation induction with human menopausal gonadotropins.

Authors:  M P Diamond; A C Wentz
Journal:  Obstet Gynecol Surv       Date:  1986-08       Impact factor: 2.347

Review 2.  Hormonal regulation of the differentiation of cultured ovarian granulosa cells.

Authors:  A J Hsueh; E Y Adashi; P B Jones; T H Welsh
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

3.  The interovarian progesterone gradient: a spatial and temporal regulator of folliculogenesis in the primate ovarian cycle.

Authors:  G S diZerega; G D Hodgen
Journal:  J Clin Endocrinol Metab       Date:  1982-03       Impact factor: 5.958

Review 4.  The dominant ovarian follicle.

Authors:  G D Hodgen
Journal:  Fertil Steril       Date:  1982-09       Impact factor: 7.329

5.  The relationship between follicular fluid steroid concentration and successful fertilization of human oocytes in vitro.

Authors:  W Botero-Ruiz; N Laufer; A H DeCherney; M L Polan; F P Haseltine; H R Behrman
Journal:  Fertil Steril       Date:  1984-06       Impact factor: 7.329

6.  One ovary or two: differences in ovulation induction, estradiol levels, and follicular development in a program for in vitro fertilization.

Authors:  M P Diamond; A C Wentz; C M Herbert; D E Pittaway; W S Maxson; J F Daniell
Journal:  Fertil Steril       Date:  1984-04       Impact factor: 7.329

7.  Asymmetric secretion of principal ovarian venous steroids in the primate luteal phase.

Authors:  E L Marut; G D Hodgen
Journal:  Steroids       Date:  1982-04       Impact factor: 2.668

8.  Three years of in vitro fertilization at Norfolk.

Authors:  H W Jones; A A Acosta; M C Andrews; J E Garcia; G S Jones; J Mayer; J S McDowell; Z Rosenwaks; B A Sandow; L L Veeck
Journal:  Fertil Steril       Date:  1984-12       Impact factor: 7.329

9.  The use of high-dose human menopausal gonadotropin in an in vitro fertilization program.

Authors:  N Laufer; A H DeCherney; F P Haseltine; M L Polan; H C Mezer; A M Dlugi; D Sweeney; F Nero; F Naftolin
Journal:  Fertil Steril       Date:  1983-12       Impact factor: 7.329

10.  Identification of proteins in pooled human follicular fluid which suppress follicular response to gonadotropins.

Authors:  G S diZerega; R P Marrs; P C Roche; J D Campeau; O R Kling
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

View more
  4 in total

1.  Long-term effects of repeated superovulation on the uterus and mammary gland in rhesus monkeys.

Authors:  Peipei Yan; Jingyi Xu; Yan Zeng; Guoying Dong; Huarong Cao; Meimei Zheng; Hui Zhu
Journal:  J Assist Reprod Genet       Date:  2017-01-23       Impact factor: 3.412

2.  Super high estradiol response to gonadotropin stimulation in patients undergoing in vitro fertilization.

Authors:  M P Diamond; T Buchholz; S P Boyers; G Lavy; B S Shapiro; A H DeCherney
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

3.  Efficient production of cynomolgus monkeys with a toolbox of enhanced assisted reproductive technologies.

Authors:  Yunhan Ma; Jiayu Li; Ge Wang; Qiong Ke; Sien Qiu; Liang Gao; Haifeng Wan; Yang Zhou; Andy Peng Xiang; Qunshan Huang; Guoping Feng; Qi Zhou; Shihua Yang
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

4.  Repeated superovulation increases the risk of osteoporosis and cardiovascular diseases by accelerating ovarian aging in mice.

Authors:  Jinjin Zhang; Zhiwen Lai; Liangyan Shi; Yong Tian; Aiyue Luo; Zheyuan Xu; Xiangyi Ma; Shixuan Wang
Journal:  Aging (Albany NY)       Date:  2018-05-22       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.